BNP Paribas Financial Markets’s Exagen XGN Stock Holding History

BNP Paribas Financial Markets’s Portfolio XGN Stock Details XGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$135	Sell	29 -19,795	-100%	-$74.5K	﹤0.01%	5783
2026 Q1	$59.5K	Sell	19,824 -113,418	-85%	-$439K	﹤0.01%	4602
2025 Q4	$810K	Buy	133,242 +86,410	+185%	+$786K	﹤0.01%	3256
2025 Q3	$515K	Buy	46,832 +46,798	+137,641%	+$414K	﹤0.01%	3532
2025 Q2	$237	Buy	34 +5	+17%	+$30	﹤0.01%	5274
2025 Q1	$104	Hold	29	–	–	﹤0.01%	5253
2024 Q4	$119	Buy	+29	New	+$104	﹤0.01%	5273
2022 Q4	–	Sell	-169	Closed	-$458	–	4678
2022 Q3	$458	Buy	+169	New	+$943	﹤0.01%	4530

Other funds holding XGN

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

MBAM

Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

BNP Paribas Financial Markets's XGN Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Exagen (XGN) stake by 100% in Q2 2026, selling an estimated $74.5K and leaving 29 shares worth $135. The position accounts for ﹤0.01% of the portfolio, ranked #5783.

BNP Paribas Financial Markets first reported a position in XGN in Q3 2022 and has held it in 8 quarters since. The position peaked at $810K in Q4 2025. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

BNP Paribas Financial Markets held 29 shares of Exagen worth $135 as of Q2 2026.
BNP Paribas Financial Markets sold 19,795 Exagen shares in Q2 2026, an estimated $74.5K.
Exagen made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5783 holding.
BNP Paribas Financial Markets first reported a position in Exagen in Q3 2022 and has held it in 8 quarters since.
BNP Paribas Financial Markets's Exagen position peaked at $810K in Q4 2025.
57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.